Welcome to Medications.com
Par Pharmaceutical Provides Summary of Analyst/Investor Day - PR Newswire (press release)
... 8 potential first-to-file ANDA submissions -- Terminated certain non-core assets -- 9 generic product launches -- Megace ES(R) sales annualizing at over ...
http://www.prnewswire.com/cgi-bin... |
Posted: Fri Sep 28 06:31:57 -0400 2007
Megace ES RSS Feed
© 2002-2007, Skylabs Inc. |
About Us |
Disclaimer/Terms of Use |
Advertise |
Contact Us |
Site Map |
Developed by:
W3matter.com |
Sleep Apnea
